N/A Completed N=28 Randomized Single-blind Prevention

Engaging Men From Blue-collar Industries in Weight Loss

Obesity

Source: ClinicalTrials.gov NCT05386238 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2025

Primary outcomePrimary: Participant Satisfaction With the Intervention — 2; 1; 0; 0 Participants

Summary

Objectives*: Primary Objective: Aim 1: Examine the acceptability of tailored behavioral weight loss program and a standard program in men working in blue-collar occupations. Aim 2: Compare recruitment approaches that vary on trust-based messaging to recruit men with overweight/obesity who work in blue-collar occupations. Secondary Objectives: Determine the feasibility of retaining participants to a randomized trial over six months.

Outcome Measures

Outcome	Result	p-value
PRIMARY Participant Satisfaction With the Intervention	2; 1; 0; 0; 3; 2	—
PRIMARY Recruitment Response	3; 1; 3; 0	—
SECONDARY Retention Rates for Each Intervention Group	11; 11	—
SECONDARY Recruitment Reach	34; 14; 17; 9	—

Eligibility Criteria

Inclusion criteria

Age 18 years and older
Male
Body mass index (BMI) > 25 kg/m2
Employed >20 hours per week in an occupation classified as blue collar
Ability to communicate in English
Provision of signed and dated informed consent form

Exclusion criteria

History of bariatric surgery
Diabetes managed with insulin
Diagnosis of a serious mental illness
Conditions contraindicated to exercise independently (determined using four questions of Physical Activity Readiness Questionnaire)
Report of potentially hazardous alcohol use (ASSIST >27)
Weight loss in the prior six months of 10 pounds or greater
Body mass index ≥60 kg/m2, due to increased injury risk with exercise
Diagnosis of an eating disorder
Any major medical condition that could increase risk for injury or other contradictions for treatment, or high likelihood of attrition, as determined by the study team

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05386238). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.